Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Risk adjusted net present value: What is the current valuation of Gilead Sciences's Seladelpar lysine?
Seladelpar lysine is a small molecule commercialized by Gilead Sciences, with a leading Pre-Registration program in Primary Biliary Cholangitis (Primary...
Seladelpar lysine by Gilead Sciences for Primary Biliary Cholangitis (Primary Biliary Cirrhosis): Likelihood of Approval
Seladelpar lysine is under clinical development by Gilead Sciences and currently in Pre-Registration for Primary Biliary Cholangitis (Primary Biliary Cirrhosis)....
Risk adjusted net present value: What is the current valuation of Gilead Sciences's Seladelpar lysine?
Seladelpar lysine is a small molecule commercialized by Gilead Sciences, with a leading Pre-Registration program in Primary Biliary Cholangitis (Primary...